13F

Stock

Enveric Biosciences, Inc.

ENVB · held by 11 managers

Reported value

$106.6K

Holders

11

+2 new · −2 exited

Holders’ est. mark

−$35.6K

Price effect on 9 books still in the name

Largest holder

$62.4K

GEODE CAPITAL MANAGEMENT, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC32.1K$62.4KNew
AdvisorShares Investments LLC17K$32.9K−$28.7KCut−$28.7K
UBS Group AG3.61K$7.01K−$4.89KCut−$3.5K
Tower Research Capital LLC (TRC)1.1K$2.14K−$1.86KCut−$4.82K
JONES FINANCIAL COMPANIES LLLP1K$1.88KNew
SBI Securities Co., Ltd.83$161−$83Cut−$17
BlackRock, Inc.51$99−$86Cut−$86
GROUP ONE TRADING LLC1$2−$2Cut−$2
NATIONAL BANK OF CANADA /FI/1$2−$2Cut−$2
DANSKE BANK A/S1$2−$2Cut−$2
WELLS FARGO & COMPANY/MN1$2−$2Cut−$2

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.